The Future of GLP-1s in Mental Health Treatment While more research is needed, early findings point to GLP-1s as promising tools in the treatment of addiction, depression, and neurodegenerative diseases
1 The standards for diabetes management from the American Diabetes Association (ADA) have evolved significantly in recent years, and their 2025 standards recommend SGLT2 inhibitors and GLP1 RAs as first-line, glucose-lowering medications for all patients with diabetes
We anticipate the Science Day will occur in the next three months in the Ozempic Lawsuit
We identified six biophysical properties that can be predicted from a sequence using the ProtParam module ( from the biopython Python package 45 : (1) the isoelectric point in neutral pH, (2) GRAVY (grand average of hydropathy) 46 , (3) the instability index 47 , (4) aromaticity, (5) the molar extinction coefficient and (6) molecular weight
Lisdexamfetamine: a prodrug for the treatment of attention-deficit/hyperactivity disorder
Even though this was an open-label trial, the neurologist who assessed the patients movements was blinded to treatment
